TheProfitWatch

OBIO - Orchestra BioMed Holdings, Inc. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.59 0.09 (2.38%) --- --- --- 0.07 (1.95%) 0.02 (0.55%) 0.0 (0.0%) 0.0 (0.0%)

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Category: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.5
Diluted EPS:
-0.5
Basic P/E:
-7.351
Diluted P/E:
-7.351
RSI(14) 1m:
100.0
VWAP:
3.68
RVol:

Events

Period Kind Movement Occurred At

Related News